Pfizer Moves Forward With Once-Daily Weight Loss Pill

(Reuters) -Pfizer said on Thursday it would advance a reworked, once-a-day version of its experimental obesity pill, danuglipron to clinical trials...

(Reuters) -Pfizer said on Thursday it would advance a reworked, once-a-day version of its experimental obesity pill, danuglipron to clinical trials...